Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 70518-3814

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-3814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Cyclobenzaprine HCl 5mg 70518 3814 01)

Mm2 (Cyclobenzaprine HCl 5mg 70518 3814 01)
Label for Cyclobenzaprine Hydrochloride 5 mg film-coated tablets. The package contains 90 tablets. It is a prescription drug repackaged by RemedyRepack Inc. Directions advise to see the package insert and store tablets between 20-25°C with permitted excursions from 15-30°C. Manufacturer is Advagen Pharma Limited, Plainsboro, NJ.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Cyclobenzaprine HCl 5 mg film-coated tablets with a quantity of 30 tablets. The label indicates it is prescription-only, repackaged by RemedyRepack Inc., and manufactured by Advagen Pharma Limited in Plainsboro, NJ. Storage instructions and a barcode with a QR code are also visible.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride showing a tricyclic ring system attached to a side chain with a hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.